BULLFROG AI HOLDINGS INC. - COMMON STOCK

Join Bullfrog AI’s Exclusive Live Investor Webinar and Q&A Session on April 23

17 Apr 2025 08:00:00 By Nasdaq GlobeNewswire

BullFrog AI and Eleison Pharmaceuticals Enter Agreement to Collaborate to Optimize Pivotal Phase 3 Trial

27 Feb 2025 08:00:01 By Nasdaq GlobeNewswire

BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week

10 Jan 2025 08:00:00 By Nasdaq GlobeNewswire

BullFrog AI Issues Letter to Stockholders

27 Dec 2024 08:00:00 By Nasdaq GlobeNewswire

BullFrog AI Announces Appointment of Chief Financial Officer

17 Dec 2024 16:30:00 By Nasdaq GlobeNewswire

BullFrog AI’s VP Artificial Intelligence to Present at Google’s Cancer AI Symposium

22 Oct 2024 07:30:00 By Nasdaq GlobeNewswire

Bullfrog AI Announces Closing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

21 Oct 2024 11:45:00 By Nasdaq GlobeNewswire

Bullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

18 Oct 2024 09:30:54 By Nasdaq GlobeNewswire

BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni

15 Oct 2024 07:30:00 By Nasdaq GlobeNewswire

BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114

09 Oct 2024 07:30:00 By Nasdaq GlobeNewswire

BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

26 Aug 2024 08:00:00 By Nasdaq GlobeNewswire

BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug Targets

25 Jul 2024 07:30:00 By Nasdaq GlobeNewswire

Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on June 12

29 May 2024 08:00:00 By Nasdaq GlobeNewswire

BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders

16 May 2024 08:00:00 By Nasdaq GlobeNewswire

BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo

09 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute

08 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer

26 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

BullFrog AI Announces Underwriter’s Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company’s Common Stock

21 Feb 2024 12:01:05 By Nasdaq GlobeNewswire

BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip

09 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

BullFrog AI Announces Closing of $5.7 Million Public Offering

05 Feb 2024 10:00:57 By Nasdaq GlobeNewswire